Skip to main content
Abbott India Ltd. logo

Abbott India Ltd. — Investor Relations & Filings

Ticker · ABBOTINDIA ISIN · INE358A01014 LEI · 5493008KZ9E3HFRN6T46 BSE.NS Manufacturing
Filings indexed 448 across all filing types
Latest filing 2021-05-18 Notice of Dividend Amou…
Country IN India
Listing BSE.NS ABBOTINDIA

About Abbott India Ltd.

https://www.abbott.co.in

Abbott India Ltd. is a pharmaceutical entity focused on providing high-quality healthcare solutions through a diverse portfolio of trusted brands. The company specializes in several key therapeutic areas, including women's health, gastroenterology, cardiology, metabolic disorders, primary care, and the central nervous system. Its product range features well-known formulations such as Duphaston, Thyronorm, Udiliv, Vertin, and Digene. The organization leverages advanced manufacturing capabilities and an extensive distribution network to serve healthcare professionals and patients. It emphasizes science-based innovation and clinical excellence to address evolving medical needs. By maintaining a strong focus on patient outcomes and therapeutic efficacy, the company has established itself as a reliable provider of pharmaceutical products across various specialized and general medical segments.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors ....
Notice of Dividend Amount Classification · 100% confidence The document is a formal letter from Abbott India Limited addressed to the stock exchange, notifying about the Board of Directors' recommendation for a final and special dividend for the fiscal year ended March 31, 2021. It mentions the dividend amounts, the condition of shareholder approval at the upcoming AGM, and the expected payment date. The document is short (1867 characters) and serves as an announcement of dividend details rather than a full financial report or detailed analysis. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2021-05-18 English
Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose a copy of the Audited Financial ....
Annual Report Classification · 95% confidence The document is titled 'Audited Financial Results for the quarter and year ended March 31, 2021' and includes detailed financial statements such as the Statement of Audited Financial Results, Statement of Assets and Liabilities, and Statement of Cash Flows. It also contains an Independent Auditor's Report on these financial results. The document references Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to quarterly and annual financial results disclosures in India. The presence of comprehensive financial data for the full fiscal year ending March 31, 2021, along with auditor's opinion, indicates this is a full annual financial report rather than a brief earnings release or an announcement. The length of the document (15,000 characters) and the inclusion of detailed financial statements confirm it is not merely an announcement or certification. Therefore, the document fits the definition of an Annual Report (10-K equivalent) for the fiscal year ended March 31, 2021.
2021-05-18 English
Please find enclosed the copies of Public Notice published as per Regulation 47 (3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, ....
Regulatory Filings
2021-05-10 English
ABBOTT INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2021 ,inter alia, to consider and approve 1. The text of Audited Financial ....
Regulatory Filings Classification · 95% confidence The document is a letter from Abbott India Limited addressed to the stock exchange (BSE Limited) informing about a scheduled Board of Directors meeting to consider and approve the audited financial results and audited financial statements for the year ended March 31, 2021, and to recommend a dividend. It also mentions the closure of the trading window as per insider trading regulations. The document is an intimation or announcement about an upcoming board meeting and financial results approval, not the financial report itself. The document length is short (2378 characters) and it does not contain actual financial data or the full audit report, but rather a notification under SEBI regulations. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance notice.
2021-05-10 English
Please find enclosed Certificate dated April 16, 2021 issued by Ms. Neena Bhatia, Practicing Company Secretary, pursuant to Regulation 40(9) of the Securities and Exchange Board of India ....
Regulatory Filings
2021-04-16 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Corporate Relations Department of BSE Limited referencing a SEBI circular about fund raising by issuance of debt securities by large entities. The letter states that Abbott India Limited is not classified as a Large Corporate as of March 31, 2021, according to the SEBI circular framework. The document is short (1517 characters), contains no financial statements or detailed financial data, and serves as a regulatory compliance confirmation or notification rather than a financial report or announcement of a report. It does not fit into categories like Capital/Financing Update (CAP) because it does not announce any financing activity, nor is it an earnings release or annual report. It is primarily a regulatory compliance communication. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements and compliance documents.
2021-04-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.